FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
18.94 |
IU/g |
2.28 |
6.46 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48855 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
|
6.51 |
ml/min/g |
2.47 |
6.54 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46194 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
|
6.06 |
ml/min/g |
1.4 |
3.42 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46200 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
5.2 |
ml/min/g |
0.62 |
1.76 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44717 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
|
8.39 |
ml/min/g |
1.49 |
3.65 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46869 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
4 |
|
0.8 |
IU/g |
0.27 |
0.54 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47443 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
15.03 |
IU/g |
2.39 |
6.75 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45972 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
70.44 |
% |
6.3 |
15.43 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46065 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.49 |
IU/g |
0.16 |
0.48 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47302 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
|
8.66 |
ml/min/g |
1.23 |
3.48 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46863 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
|
8.54 |
ml/min/g |
1.1 |
2.21 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44711 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
18.13 |
IU/g |
2.51 |
6.15 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48865 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
75.74 |
% |
11.64 |
32.92 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46059 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
6 |
|
0.39 |
IU/g |
0.05 |
0.13 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47316 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
post-ischemic value/pre-ischemic value x 100% |
66.0 |
% |
4.33 |
8.66 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47070 |
461 |
FHH-Chr 10BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
55.33 |
% |
5.02 |
13.28 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47076 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
4 |
|
13.0 |
ml/min/g |
1.49 |
2.98 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46646 |
461 |
FHH-Chr 10BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
9.74 |
ml/min/g |
1.07 |
3.02 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46652 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.53 |
IU/g |
0.14 |
0.41 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47454 |
461 |
FHH-Chr 10BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
4 |
|
16.85 |
IU/g |
1.82 |
3.65 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45965 |
461 |